VRNA Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Verona Pharma PLC - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 15.55 USD -0.26%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast VRNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VRNA is 34.53 USD with a low forecast of 31.31 USD and a high forecast of 39.9 USD.

VRNA Lowest Forecast

Wall Street Target

VRNA Average Forecast

Wall Street Target

VRNA Highest Forecast

Wall Street Target

101% Upside

122% Upside

157% Upside

The latest public price target was made on Apr 16, 2024 by Yasmeen Rahimi from Piper Sandler , who expects VRNA stock to rise by 132% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Yasmeen Rahimi Piper Sandler	36 USD Upside 132%	1 week ago Apr 16, 2024	Verona Pharma (VRNA) PT Raised to $36 at Piper Sandler StreetInsider

Price Target	36 USD
Upside/Downside	132%

Prophase Labs Inc

295% Upside

Elanco Animal Health Inc

36% Upside

Guangdong Zhongsheng Pharmaceutical Co Ltd

47% Downside

ATAI Life Sciences NV

483% Upside

Prophase Labs Inc

295% Upside

Elanco Animal Health Inc

36% Upside

Guangdong Zhongsheng Pharmaceutical Co Ltd

47% Downside

ATAI Life Sciences NV

483% Upside

Torrent Pharmaceuticals Ltd

2% Downside

Shinpoong Pharmaceutical Co Ltd

57% Downside

Shenzhen Salubris Pharmaceuticals Co Ltd

26% Upside

F D C Ltd

22% Downside

Revenue
Forecast

N/A

N/A

N/A

N/A

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

-4%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-63%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for VRNA is 34.53 USD with a low forecast of 31.31 USD and a high forecast of 39.9 USD.

Join more than 131,000+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.